DK2803366T3 - Sammensætninger til behandling eller forebyggelse af oxalat-relateret sygdom - Google Patents
Sammensætninger til behandling eller forebyggelse af oxalat-relateret sygdom Download PDFInfo
- Publication number
- DK2803366T3 DK2803366T3 DK14180734.7T DK14180734T DK2803366T3 DK 2803366 T3 DK2803366 T3 DK 2803366T3 DK 14180734 T DK14180734 T DK 14180734T DK 2803366 T3 DK2803366 T3 DK 2803366T3
- Authority
- DK
- Denmark
- Prior art keywords
- oxalate
- enzymes
- compositions
- reducing
- bacteria
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
- C12Y102/03—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with oxygen as acceptor (1.2.3)
- C12Y102/03004—Oxalate oxidase (1.2.3.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y208/00—Transferases transferring sulfur-containing groups (2.8)
- C12Y208/03—CoA-transferases (2.8.3)
- C12Y208/03016—Formyl-CoA transferase (2.8.3.16)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/01—Carboxy-lyases (4.1.1)
- C12Y401/01002—Oxalate decarboxylase (4.1.1.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/01—Carboxy-lyases (4.1.1)
- C12Y401/01008—Oxalyl-CoA decarboxylase (4.1.1.8)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
Claims (4)
1. Farmaceutisk sammensætning omfattende oxalat-decarboxylase, til anvendelse i den terapeutiske behandling afen oxalat-relateret sygdom ved at reducere en oxalat-koncentration hos et menneske, hvor sammensætningen administreres mere end én gang om dagen kontinuerligt hver dag i en periode på måneder eller år og hvor nævnte oxalat-relateret sygdom er valgt fra gruppen bestående af hyperoxaluri, primær hyperoxaluri, idiopatisk calcium-oxalat-nyrestenssygdom (urolithiasis) og enterisk hyperoxaluri.
2. Den farmaceutiske sammensætning til anvendelse ifølge krav 1, hvor sammensætningen omfatter en enterisk coating.
3. Den farmaceutiske sammensætning til anvendelse ifølge et hvilket som helst af kravene 1-2, hvor det ene eller flere enzymer er til stede i en mængde på 5 til 5000 aktivitetsenheder af oxalat-reducerende enzymaktivitet.
4. Den farmaceutiske sammensætning til anvendelse ifølge et hvilket som helst af kravene 1-3, hvor sammensætningen yderligere omfatter coenzymer og/eller co-faktorer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/868,242 US8486389B2 (en) | 1997-05-23 | 2004-06-15 | Compositions and methods for treating or preventing oxalate-related disease |
EP05786347.4A EP1771201B1 (en) | 2004-06-15 | 2005-06-15 | Compositions and methods for treating or preventing oxalate-related disease |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2803366T3 true DK2803366T3 (da) | 2018-11-05 |
Family
ID=35510266
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05786347.4T DK1771201T3 (da) | 2004-06-15 | 2005-06-15 | Sammensætninger og fremgangsmåder til behandling eller forebyggelse af oxalat-relateret sygdom |
DK14180734.7T DK2803366T3 (da) | 2004-06-15 | 2005-06-15 | Sammensætninger til behandling eller forebyggelse af oxalat-relateret sygdom |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05786347.4T DK1771201T3 (da) | 2004-06-15 | 2005-06-15 | Sammensætninger og fremgangsmåder til behandling eller forebyggelse af oxalat-relateret sygdom |
Country Status (13)
Country | Link |
---|---|
US (3) | US8486389B2 (da) |
EP (2) | EP1771201B1 (da) |
CN (2) | CN104998253A (da) |
CY (2) | CY1115745T1 (da) |
DK (2) | DK1771201T3 (da) |
ES (2) | ES2692148T3 (da) |
HK (2) | HK1198922A1 (da) |
LT (1) | LT2803366T (da) |
PL (2) | PL1771201T3 (da) |
PT (2) | PT1771201E (da) |
SI (2) | SI2803366T1 (da) |
TR (1) | TR201815200T4 (da) |
WO (1) | WO2005123116A2 (da) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8486389B2 (en) | 1997-05-23 | 2013-07-16 | Oxthera, Inc. | Compositions and methods for treating or preventing oxalate-related disease |
JP2005537037A (ja) * | 2001-10-05 | 2005-12-08 | イクシオン・バイオテクノロジー・インコーポレーテッド | 流体の蓚酸塩濃度を減少させる物質および方法 |
US7785635B1 (en) * | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
WO2005110469A2 (en) * | 2004-05-07 | 2005-11-24 | Oxthera, Inc. | Methods and compositions for reducing oxalate concentrations |
DK1880001T3 (da) | 2005-05-31 | 2011-09-12 | Iams Company | Feline probiotiske lactobacilli |
CA2607949C (en) | 2005-05-31 | 2012-09-25 | Thomas William-Maxwell Boileau | Feline probiotic bifidobacteria |
CA2610159C (en) | 2005-06-10 | 2015-03-31 | Altus Pharmaceuticals Inc. | Methods to reduce oxalate concentration by administration of oxalate oxidase crystals |
AU2005339139A1 (en) * | 2005-12-14 | 2007-06-21 | Oxthera, Inc. | Pharmaceutical compositions and methods for treating or preventing oxalate-related disease |
DE602006020347D1 (de) * | 2005-12-16 | 2011-04-07 | Oxthera Inc | Zusammensetzungen und verfahren zur oxalatreduktion |
EP2046373B1 (en) * | 2006-08-02 | 2013-03-20 | Althea Technologies, Inc. | Crystallized oxalate decarboxylase and methods of use |
AU2008211600B8 (en) | 2007-02-01 | 2014-02-13 | Mars, Incorporated | Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
FR2936952A1 (fr) * | 2008-10-09 | 2010-04-16 | Monique Bellec | Administration par voie orale de medicaments et complements nutritionnels |
CN101554237B (zh) * | 2009-03-16 | 2013-11-06 | 武汉康复得生物科技有限公司 | 植物纤维或微生物不溶组分中的草酸降解酶的制备方法 |
US8431122B2 (en) | 2009-07-02 | 2013-04-30 | Oxthera Intellectual Property Ab | Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes |
ES2673269T3 (es) | 2009-07-02 | 2018-06-21 | Oxthera Intellectual Property Ab | Purificación y aislamiento de enzimas de degradación de oxalato recombinantes |
DK2449098T3 (da) * | 2009-07-02 | 2017-03-06 | Oxthera Intellectual Property Ab | Oprensning og isolering af rekombinante oxalat-nedbrydende enzymer og sprøjtetørrede partikler indeholdende oxalat-nedbrydende enzymer |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
EP2504428A4 (en) * | 2009-11-25 | 2013-09-25 | Captozyme Llc | METHOD AND COMPOSITIONS FOR TREATING OXALATE-MEDIATED SUFFERING |
WO2014113648A1 (en) | 2013-01-18 | 2014-07-24 | Allena Pharmaceuticals, Inc. | Crystallized oxalate decarboxylase and methods of use |
JP6574414B2 (ja) | 2013-06-07 | 2019-09-11 | アレナ ファーマシューティカルズ, インコーポレイテッド | 透析のための組成物、方法、および器具 |
WO2015002588A1 (en) * | 2013-07-05 | 2015-01-08 | Oxthera Intellectual Property Ab | Secretagogues derived from oxalobacter formigenes |
WO2016161455A2 (en) | 2015-04-02 | 2016-10-06 | Captozyme, Llc | High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate |
TN2018000420A1 (en) * | 2016-06-13 | 2020-06-15 | Oxthera Intellectual Property Ab | Compositions and methods for the treatment or prevention of oxalate-related disorders |
AU2017376780A1 (en) | 2016-12-15 | 2019-07-04 | Novome Biotechnologies, Inc. | Compositions and methods for modulating growth of a genetically modified gut bacterial cell |
WO2020018799A1 (en) | 2018-07-18 | 2020-01-23 | The University Of Chicago | Compositions comprising sel1-derived peptides and methods of treatment/prevention of excess oxalate levels and associated conditions/diseases therewith |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4205132A (en) * | 1978-07-17 | 1980-05-27 | Microlife Technics, Inc. | Lyophilization of bacteria |
DE3030185A1 (de) | 1980-08-07 | 1982-04-08 | Kohlbecker, Günther, 3000 Hannover | Verfahren zur enzymatischen entfernung von oxalat mittels oxalat-oxidase |
DE3204284A1 (de) | 1982-02-06 | 1983-08-18 | Kohlbecker, Günther, 3000 Hannover | Verfahren zur enzymatischen entfernung von sauerstoff |
JPS5968344A (ja) | 1982-10-12 | 1984-04-18 | Agency Of Ind Science & Technol | 非対称機能膜及びその製法 |
US4888182A (en) | 1983-04-11 | 1989-12-19 | Board Of Regents Of The University Of Texas System | Compositions and methods of treating calcium renal stones |
US4539118A (en) | 1984-03-23 | 1985-09-03 | Sigma Chemical Company | Rapid, accurate method of separation of oxalate from urine and other biological fluids |
US5263992A (en) * | 1986-10-17 | 1993-11-23 | Bio-Metric Systems, Inc. | Biocompatible device with covalently bonded biocompatible agent |
US5427935A (en) * | 1987-07-24 | 1995-06-27 | The Regents Of The University Of Michigan | Hybrid membrane bead and process for encapsulating materials in semi-permeable hybrid membranes |
US5279827A (en) | 1991-01-16 | 1994-01-18 | Allegheny-Singer Research Institute | Extract and pharmaceutical composition for treatment of calcium oxalate stone disease and viral infections |
US5206219A (en) * | 1991-11-25 | 1993-04-27 | Applied Analytical Industries, Inc. | Oral compositions of proteinaceous medicaments |
US5286495A (en) * | 1992-05-11 | 1994-02-15 | University Of Florida | Process for microencapsulating cells |
HU219140B (hu) * | 1992-11-30 | 2001-02-28 | Zeneca Ltd. | Oxalát-dekarboxilázt kódoló izolált DNS fragmens, az azt tartalmazó rekombináns molekula, és a rekombináns molekulát tartalmazó transzformált növényi sejtek |
AU6701694A (en) * | 1993-04-16 | 1994-11-08 | Mccormick & Company, Inc. | Encapsulation compositions |
US5554147A (en) * | 1994-02-01 | 1996-09-10 | Caphco, Inc. | Compositions and devices for controlled release of active ingredients |
US5788687A (en) * | 1994-02-01 | 1998-08-04 | Caphco, Inc | Compositions and devices for controlled release of active ingredients |
US5505713A (en) | 1994-04-01 | 1996-04-09 | Minimed Inc. | Indwelling catheter with stable enzyme coating |
JPH10500019A (ja) | 1994-05-18 | 1998-01-06 | ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド | ヒトのオキサリル−CoAデカルボキシラーゼ |
US6090628A (en) * | 1994-06-20 | 2000-07-18 | University Of Florida | Materials and methods for detection of Oxalobactor formigenes |
US5912125A (en) | 1994-06-20 | 1999-06-15 | University Of Florida | Materials and methods for detection of oxalobacter |
US6214980B1 (en) * | 1994-06-20 | 2001-04-10 | University Of Florida | Materials and methods for detection of Oxalobacte formigenes |
US5604111A (en) | 1994-06-20 | 1997-02-18 | University Of Florida Research Foundation | Method and kit for detection of oxalate |
US6033719A (en) * | 1996-04-25 | 2000-03-07 | Medtronic, Inc. | Method for covalent attachment of biomolecules to surfaces of medical devices |
SE9603029D0 (sv) | 1996-08-20 | 1996-08-20 | Svenska Traeforskningsinst | Method for lowering the level of oxalic acid |
US6297425B1 (en) | 1997-03-21 | 2001-10-02 | Pioneer Hi-Bred International, Inc. | Gene encoding oxalate decarboxylase from aspergillus phoenices |
US6355242B1 (en) * | 1997-05-23 | 2002-03-12 | Ixion Biotechnology, Inc. | Materials and methods for treating or preventing oxalate-related disease |
DE69841200D1 (de) | 1997-05-23 | 2009-11-12 | Oxthera Inc | Oxalate-abbauende mikroorganismen oder oxalate-abbauende enzyme zur verhütung der oxalate-verwandten krankheiten |
US8486389B2 (en) | 1997-05-23 | 2013-07-16 | Oxthera, Inc. | Compositions and methods for treating or preventing oxalate-related disease |
US20040120941A1 (en) | 1997-05-23 | 2004-06-24 | Allison Milton J. | Materials and methods for treating or preventing oxalate-related disease |
US6080404A (en) * | 1997-09-05 | 2000-06-27 | University Of Florida | Materials and methods for removal of substances from fluids |
US6566407B2 (en) * | 1997-11-05 | 2003-05-20 | Geltex Pharmaceuticals, Inc. | Method for reducing oxalate |
US5985938A (en) * | 1997-11-05 | 1999-11-16 | Geltex Pharmaceuticals, Inc. | Method for reducing oxalate |
US6203797B1 (en) | 1998-01-06 | 2001-03-20 | Stephen C. Perry | Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome |
US6153252A (en) * | 1998-06-30 | 2000-11-28 | Ethicon, Inc. | Process for coating stents |
JP5408684B2 (ja) | 1998-10-09 | 2014-02-05 | ゼネラル ミルズ インコーポレイテッド | 非連続な保存安定粒子を得るためにマトリックスに感受性液体成分を封入する方法 |
IT1309427B1 (it) * | 1999-05-28 | 2002-01-23 | Mendes S U R L | Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso |
CZ20014319A3 (cs) | 1999-06-07 | 2002-04-17 | Nanosphere, Inc. | Způsob potahování jádrového materiálu a potahované částice |
DE10026541A1 (de) | 2000-05-27 | 2001-11-29 | Zeiss Carl | Vorrichtung zur präzisen Positionierung eines Bauteils, insbesondere eines optischen Bauteiles |
JP2005537037A (ja) | 2001-10-05 | 2005-12-08 | イクシオン・バイオテクノロジー・インコーポレーテッド | 流体の蓚酸塩濃度を減少させる物質および方法 |
US7407668B2 (en) * | 2002-01-24 | 2008-08-05 | Boston Scimed, Inc. | Medical articles having enzymatic surfaces for localized therapy |
US6929940B1 (en) * | 2002-08-20 | 2005-08-16 | University Of Florida Research Foundation, Inc. | Polynucleotides encoding oxalate decarboxylase from Aspergillus niger and methods of use |
WO2004018634A2 (en) | 2002-08-20 | 2004-03-04 | University Of Florida | Polynucleotide encoding oxalate decarboxylase from aspergillus niger and methods of use |
WO2005110469A2 (en) | 2004-05-07 | 2005-11-24 | Oxthera, Inc. | Methods and compositions for reducing oxalate concentrations |
AU2005339139A1 (en) | 2005-12-14 | 2007-06-21 | Oxthera, Inc. | Pharmaceutical compositions and methods for treating or preventing oxalate-related disease |
DE602006020347D1 (de) | 2005-12-16 | 2011-04-07 | Oxthera Inc | Zusammensetzungen und verfahren zur oxalatreduktion |
EP2046373B1 (en) | 2006-08-02 | 2013-03-20 | Althea Technologies, Inc. | Crystallized oxalate decarboxylase and methods of use |
US8431122B2 (en) | 2009-07-02 | 2013-04-30 | Oxthera Intellectual Property Ab | Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes |
-
2004
- 2004-06-15 US US10/868,242 patent/US8486389B2/en not_active Expired - Fee Related
-
2005
- 2005-06-15 PL PL05786347T patent/PL1771201T3/pl unknown
- 2005-06-15 SI SI200532230T patent/SI2803366T1/sl unknown
- 2005-06-15 DK DK05786347.4T patent/DK1771201T3/da active
- 2005-06-15 ES ES14180734.7T patent/ES2692148T3/es active Active
- 2005-06-15 TR TR2018/15200T patent/TR201815200T4/tr unknown
- 2005-06-15 PT PT57863474T patent/PT1771201E/pt unknown
- 2005-06-15 EP EP05786347.4A patent/EP1771201B1/en active Active
- 2005-06-15 CN CN201510303264.9A patent/CN104998253A/zh active Pending
- 2005-06-15 EP EP14180734.7A patent/EP2803366B1/en not_active Revoked
- 2005-06-15 LT LTEP14180734.7T patent/LT2803366T/lt unknown
- 2005-06-15 PT PT14180734T patent/PT2803366T/pt unknown
- 2005-06-15 ES ES05786347.4T patent/ES2522898T3/es active Active
- 2005-06-15 CN CNA2005800241721A patent/CN101166421A/zh active Pending
- 2005-06-15 SI SI200531905T patent/SI1771201T1/sl unknown
- 2005-06-15 PL PL14180734T patent/PL2803366T3/pl unknown
- 2005-06-15 DK DK14180734.7T patent/DK2803366T3/da active
- 2005-06-15 WO PCT/US2005/021134 patent/WO2005123116A2/en active Application Filing
-
2013
- 2013-06-17 US US13/919,266 patent/US10149866B2/en active Active
-
2014
- 2014-10-16 CY CY20141100853T patent/CY1115745T1/el unknown
- 2014-12-11 HK HK14112457.5A patent/HK1198922A1/xx not_active IP Right Cessation
-
2016
- 2016-04-08 HK HK16104053.8A patent/HK1216080A1/zh unknown
-
2018
- 2018-09-18 US US16/134,793 patent/US10653726B2/en active Active
- 2018-10-23 CY CY181101090T patent/CY1120782T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CN101166421A (zh) | 2008-04-23 |
PL2803366T3 (pl) | 2018-12-31 |
US10653726B2 (en) | 2020-05-19 |
CY1120782T1 (el) | 2019-12-11 |
US20190091268A1 (en) | 2019-03-28 |
ES2692148T3 (es) | 2018-11-30 |
EP2803366A3 (en) | 2015-02-18 |
PT2803366T (pt) | 2018-11-06 |
HK1198922A1 (en) | 2015-06-19 |
US20140030324A1 (en) | 2014-01-30 |
PL1771201T3 (pl) | 2015-01-30 |
TR201815200T4 (tr) | 2018-11-21 |
WO2005123116A3 (en) | 2008-01-03 |
EP1771201A2 (en) | 2007-04-11 |
ES2522898T3 (es) | 2014-11-19 |
EP2803366A2 (en) | 2014-11-19 |
US10149866B2 (en) | 2018-12-11 |
CY1115745T1 (el) | 2017-01-25 |
WO2005123116A2 (en) | 2005-12-29 |
EP1771201A4 (en) | 2011-01-19 |
HK1216080A1 (zh) | 2016-10-14 |
US8486389B2 (en) | 2013-07-16 |
DK1771201T3 (da) | 2014-11-03 |
PT1771201E (pt) | 2014-11-06 |
CN104998253A (zh) | 2015-10-28 |
LT2803366T (lt) | 2018-12-27 |
EP1771201B1 (en) | 2014-08-13 |
SI1771201T1 (sl) | 2014-12-31 |
EP2803366B1 (en) | 2018-08-01 |
SI2803366T1 (sl) | 2018-12-31 |
US20040234514A1 (en) | 2004-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10653726B2 (en) | Compositions and methods for treating or preventing oxalate-related disease | |
EP1962873B1 (en) | Pharmaceutical compositions comprising oxalate-reducing bacteria | |
US6355242B1 (en) | Materials and methods for treating or preventing oxalate-related disease | |
US6200562B1 (en) | Method for reducing absorption of dietary oxalate using enzymes and microbes | |
US20040120941A1 (en) | Materials and methods for treating or preventing oxalate-related disease | |
DK1965816T3 (da) | Farmaceutiske sammensætninger og fremgangsmåder til behandling eller forebyggelse af oxalat-relateret sygdom | |
MXPA99010790A (en) | Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease |